Skip to main content

Find Clinical Trials

Home
Conditions
Peritoneal Cancer

Clinical trial condition

Peritoneal Cancer

Explore clinical trials studying Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

104 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Peritoneal Cancer trial results

Completed

Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers

NCT00343044

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Virginia Mason Medical Center Seattle, Washington, United States

Puget Sound Oncology Consortium (PSOC) Seattle, Washington, United States

View Trial Details

Completed

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT00267696

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: The Ohio State University & James Cancer Hospital Columbus, Ohio, United States

View Trial Details

Completed

Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer

NCT01104675

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

University of Chicago Medical Center Chicago, Illinois, United States

Indiana University Simon Cancer Center Indianapolis, Indiana, United States

Dana Farber/Partners Cancer Care Boston, Massachusetts, United States

View Trial Details

Completed

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

NCT00850772

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +24 more
Locations: The Wesley Hospital Auchenflower, Queensland, Australia

Brisbane Private Hospital Brisbane, Queensland, Australia

Greenslopes Private Hospital Greenslopes, Queensland, Australia

Royal Brisbane and Women's Hospital Herston, Queensland, Australia

View Trial Details

Completed

A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer

NCT00683241

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

NCT00491855

Conditions: Peritoneal Cancer
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer

NCT00672295

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

NCT00501644

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Precision Therapeutics, Inc. Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

NCT00189358

Conditions: Adnexal Diseases, Cancer of the Fallopian Tube, Endocrine Gland Neoplasms, +17 more
Locations: Dept. of Gynecology, Evangelisches Krankenhaus Düsseldorf, Germany

View Trial Details